Hematological and Biochemical Safety of Monthly Lokivetmab in Indian Dogs with Moderate to Severe Atopic Dermatitis
Sundararajan.R.C, Ambily.V.R, Arun George, Madhavan Unny.N, Marykuty Thomas, Divya P.D & Priya M.N · Journal of Advances in Biology & Biotechnology · 2025
Aims: To evaluate the hematological and biochemical safety profile of lokivetmab in client-owned dogs diagnosed with moderate to severe canine atopic dermatitis (CAD) over a 90-day treatment period. Study Design: Prospective, longitudinal clinical safety study. Place and Duration...
Open access
Research Article
10.9734/jabb/2025/v28i72671